HemaSphere (Aug 2023)
PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE.
- Kmira Zahra,
- Imtinène Belaid,
- Karima Kacem,
- Moez Elloumi,
- Amel Mezlini,
- Fehmi Msaddek,
- Ben Othman Tarek,
- Toumi Nabil,
- Raihane Ben Lakhal,
- Abderrahim Khelif,
- Ben Ahmed Slim,
- Khanfir Afef,
- Adnene Laatiri
Affiliations
- Kmira Zahra
- 1 Farhat Hached Hospital, department of clinical hematology, Sousse, Tunisia
- Imtinène Belaid
- 2 Farhat Hached Hospital, Department of Clinical Oncology, Sousse, Tunisia
- Karima Kacem
- 3 Aziza Othmana Hospital, department of clinical hematology, Tunis, Tunisia
- Moez Elloumi
- 4 Hedi Chaker Hospital, department of clinical hematology, sfax, Tunisia
- Amel Mezlini
- 5 Salah Azaiez Institute, Department of Clinical Oncology, Tunis, Tunisia
- Fehmi Msaddek
- 6 Military Hospital, department of clinical hematology, tunis, Tunisia
- Ben Othman Tarek
- 7 Bone marrow transplantation center, department of clinical hematology, tunis, Tunisia
- Toumi Nabil
- 8 Habib Bourguiba Hospital, Department of Clinical Oncology, sfax, Tunisia
- Raihane Ben Lakhal
- 9 Aziza Othmana Hospital, department of clinical hematology, Tunisia
- Abderrahim Khelif
- 1 Farhat Hached Hospital, department of clinical hematology, Sousse, Tunisia
- Ben Ahmed Slim
- 2 Farhat Hached Hospital, Department of Clinical Oncology, Sousse, Tunisia
- Khanfir Afef
- 8 Habib Bourguiba Hospital, Department of Clinical Oncology, sfax, Tunisia
- Adnene Laatiri
- 10 Fattouma Bourguiba Hospital, department of clinical hematology, Monastir, Tunisia
- DOI
- https://doi.org/10.1097/01.HS9.0000976080.53739.d2
- Journal volume & issue
-
Vol. 7
p. e53739d2
Abstract
No abstracts available.